GO:0097350 neutrophil clearance: Senescent Neutrophil Removal Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097350 neutrophil clearance is the selective elimination of senescent neutrophils from the body by autoregulatory mechanisms.
• Clearance is executed mainly by tissue-resident macrophages in the bone marrow, liver, spleen and other tissues, and it is a homeostatic, not merely inflammatory, process.
• The process is circadian: neutrophils age in the circulation, upregulate CXCR4, return to the bone marrow and are phagocytosed, which rhythmically modulates the hematopoietic niche.
• Defective clearance causes neutrophil accumulation and tissue damage, and has been linked to myeloproliferative neoplasms, myelofibrosis, bronchiectasis and cerebral ischemia-reperfusion injury.
• Restoring clearance of senescent neutrophils by tissue-resident macrophages limits organ aging, identifying clearance as a tractable anti-aging target.
• Key experimental handles include CXCR4/CXCL12 axis modulation, macrophage phagocytic receptors such as CD24, and efferocytosis assays in KO, knock-in and reporter models.
Description
GO:0097350 neutrophil clearance is the biological process defined as the selective elimination of senescent neutrophils from the body by autoregulatory mechanisms. Neutrophils are the most abundant circulating leukocytes and are produced continuously in the bone marrow; because they are short-lived and highly cytotoxic when activated, their removal must be tightly controlled to avoid collateral tissue injury. Clearance is therefore not simply the end of a neutrophil's life but an active, regulated homeostatic program that couples granulopoiesis in the marrow to the number of aged cells that need to be removed. The process is executed largely by professional phagocytes, especially tissue-resident macrophages, which recognize senescent neutrophils and engulf them before they can release damaging granule contents or neutrophil extracellular traps. This recognition step is receptor-dependent and can be modulated by immune checkpoint molecules such as CD24, which marks aged neutrophils for elimination. Importantly, clearance is not uniform across the body: it follows a circadian rhythm, so that neutrophil egress from and return to the bone marrow oscillates over the day and shapes the hematopoietic niche. Because of this dual role in immune surveillance and tissue protection, neutrophil clearance sits at the intersection of hematology, inflammation biology and aging research. Researchers study GO:0097350 to understand how the body disposes of spent neutrophils, why this disposal fails in disease, and whether restoring it can limit organ damage or aging.
neutrophil clearance At A Glance
| GO ID | GO:0097350 |
|---|---|
| GO term | neutrophil clearance |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | The selective elimination of senescent neutrophils from the body by autoregulatory mechanisms |
| Major function | Homeostatic removal of aged neutrophils, limiting tissue damage and modulating granulopoiesis |
| Principal effectors | Tissue-resident macrophages and other professional phagocytes |
| Key recognition axis | CXCR4/CXCL12-mediated return of aged neutrophils to the bone marrow and CD24-dependent checkpoint recognition |
| Physiological rhythm | Circadian oscillation of neutrophil aging and clearance that modulates the hematopoietic niche |
| Disease relevance | Myeloproliferative neoplasms, myelofibrosis, bronchiectasis, cerebral ischemia-reperfusion injury and organ aging |
What Is GO:0097350?
In plain terms, GO:0097350 neutrophil clearance describes how the body finds and removes old, worn-out neutrophils so that they do not accumulate and cause harm. The QuickGO definition states that it is the selective elimination of senescent neutrophils from the body by autoregulatory mechanisms. Two features are essential. First, the process is selective: it targets senescent or aged neutrophils rather than all neutrophils indiscriminately, which preserves the useful circulating pool. Second, it is autoregulatory: the removal of aged cells feeds back on the production and release of new neutrophils, so that clearance itself helps set the size of the neutrophil compartment. Mechanistically, clearance depends on recognition of aged neutrophils by phagocytes, on phagocytic uptake, and on downstream degradation of the engulfed cell, with tissue-resident macrophages acting as the principal effectors in many organs. The process is distinct from neutrophil apoptosis alone, because apoptosis is the cell-intrinsic death program, whereas clearance is the active removal of the senescent cell by the body.
Why Is neutrophil clearance Important in Cell Biology?
Neutrophil clearance matters because it is the disposal arm of neutrophil homeostasis: without efficient removal of senescent neutrophils, these cells persist, degranulate and can release neutrophil extracellular traps, driving chronic inflammation and tissue injury. Because clearance is autoregulatory, it also controls the size of the hematopoietic niche and the rate of granulopoiesis, linking the immune system to bone marrow function. Clinically, defective clearance is now recognized as a driver rather than a bystander in several diseases, including JAK2V617F myeloproliferative neoplasms where impaired clearance promotes myelofibrosis through an immune checkpoint mechanism. Conversely, restoring clearance of senescent neutrophils by tissue-resident macrophages limits organ aging, which positions this process as a candidate therapeutic node in age-related disease. In the lung, neutrophilic inflammation in bronchiectasis reflects an imbalance between neutrophil recruitment and effective clearance. In the brain, neutrophil mobilization after ischemia-reperfusion injury changes microglial function and worsens injury, underscoring how neutrophil fate decisions influence organ outcomes.
• Maintains neutrophil homeostasis by removing senescent cells before they release toxic granule contents.
• Prevents collateral tissue damage from persistent neutrophil activation and neutrophil extracellular trap formation.
• Couples clearance to granulopoiesis, thereby regulating the hematopoietic niche.
• Is circadian, so it links daily rhythms to immune cell turnover and marrow function.
• Is defective in JAK2V617F myeloproliferative neoplasms and contributes to myelofibrosis via CD24.
• Restoring clearance limits organ aging, making it an anti-aging research target.
• Contributes to the pathophysiology of neutrophilic airway disease such as bronchiectasis.
• Influences outcomes after cerebral ischemia-reperfusion injury through neutrophil-microglia crosstalk.
• Provides a mechanistic framework for understanding how pathogens such as Staphylococcus aureus modulate neutrophil effector function.
• Offers experimental entry points for CRISPR-based dissection of phagocytic recognition and clearance pathways.
What Happens During neutrophil clearance?
Neutrophil aging and acquisition of a clearance signal
In simple terms: Neutrophils get old in the blood and change their surface markers so the body knows they should be removed.
As neutrophils circulate, they age and alter their surface phenotype, including chemokine receptor expression, which changes where they go and how they are recognized. Aged neutrophils upregulate CXCR4, which directs them back toward CXCL12-rich niches such as the bone marrow, the site where much of the clearance occurs. This aging program is not random; it is rhythmic, so that the number of aged neutrophils available for clearance oscillates over the circadian cycle. The aged phenotype is what makes the process selective, because only senescent cells are targeted for elimination.
Recognition of senescent neutrophils by phagocytes
In simple terms: Macrophages use receptor signals to recognize which neutrophils are old and should be eaten.
Clearance depends on recognition of senescent neutrophils by professional phagocytes, principally tissue-resident macrophages. This recognition can be mediated by immune checkpoint molecules; CD24 has been identified as a checkpoint that marks aged neutrophils for elimination, and its dysregulation impairs clearance in myeloproliferative neoplasms. Recognition is therefore a regulated step rather than a passive consequence of cell death, and it determines whether a senescent neutrophil is removed or persists. Because macrophages reside in specific tissues, recognition also determines where clearance occurs.
Phagocytic uptake and degradation
In simple terms: Once recognized, the old neutrophil is engulfed and broken down inside the macrophage.
Following recognition, macrophages engulf senescent neutrophils and degrade them intracellularly, completing the clearance event. This uptake removes the aged cell before it can release damaging contents, which is the protective purpose of the process. Efficient uptake by tissue-resident macrophages is required for the beneficial effects of clearance on organ health, as shown by the finding that restored clearance of senescent neutrophils limits organ aging. Failure at this step leads to accumulation of senescent neutrophils and their toxic cargo.
Autoregulatory feedback on granulopoiesis
In simple terms: Removing old neutrophils sends a signal back to the bone marrow to adjust how many new ones are made.
Neutrophil clearance is autoregulatory: the removal of senescent neutrophils feeds back on the hematopoietic niche and modulates granulopoiesis. Rhythmic clearance in the bone marrow modulates the niche, coupling the daily removal of aged cells to the production and release of new neutrophils. This feedback is why clearance is considered a homeostatic process rather than a purely inflammatory one. When clearance is defective, the feedback is disrupted, and the resulting accumulation of neutrophils contributes to pathology such as myelofibrosis.
Tissue-specific and context-dependent clearance
In simple terms: Different organs clear neutrophils in different ways, and injury or infection can change the rules.
Clearance occurs in multiple tissues and is shaped by local macrophage populations, so its efficiency varies by organ. In the lung, persistent neutrophilic inflammation in bronchiectasis reflects an imbalance between recruitment and effective clearance. In the brain, neutrophil mobilization after ischemia-reperfusion injury triggers microglial functional change and exacerbates injury, showing that neutrophil fate decisions influence non-phagocytic cell populations. Pathogens can also modulate neutrophil effector programs, as Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst, altering the inflammatory context in which clearance occurs.
Key Genes Involved in GO:0097350 neutrophil clearance
The genes and proteins below are the principal molecules implicated in neutrophil clearance, spanning neutrophil aging, chemokine guidance, phagocytic recognition, macrophage effector function and inflammatory modulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCR4 | Chemokine receptor upregulated on aged neutrophils that directs their return to bone marrow niches | Central to the aging step of clearance and to circadian clearance studies |
| CXCL12 | Bone marrow chemokine ligand that retains and positions neutrophils for clearance | Defines the niche where clearance occurs |
| CD24 | Immune checkpoint molecule that marks aged neutrophils for elimination | Directly implicated in defective clearance in myeloproliferative neoplasms |
| JAK2 | Kinase whose V617F mutation drives myeloproliferative neoplasms with defective neutrophil clearance | Key disease gene linking clearance failure to myelofibrosis |
| PTPRC (CD45) | Leukocyte phosphatase that modulates neutrophil signaling and lifespan | Useful marker and functional node in neutrophil biology |
| ITGAM (CD11b) | Integrin involved in neutrophil adhesion and phagocytic recognition | Relevant to uptake and adhesion steps |
| MERTK | Macrophage receptor tyrosine kinase mediating efferocytosis | Candidate effector of senescent neutrophil uptake |
| AXL | Macrophage receptor tyrosine kinase involved in clearance of apoptotic cells | Candidate effector of efferocytosis |
| GAS6 | Ligand for TAM receptors that bridges phagocytes and target cells | Modulates recognition and uptake efficiency |
| MFGE8 | Opsonin that bridges phosphatidylserine on target cells to phagocyte integrins | Mechanistic handle for recognition assays |
| ELANE | Neutrophil serine protease stored in granules | Marker of granule cargo whose release is prevented by timely clearance |
| MPO | Myeloperoxidase involved in oxidative burst and neutrophil effector function | Readout of neutrophil activation state |
| ACOD1 (IRG1) | Enzyme producing itaconate in neutrophils | Links pathogen stimulation to suppression of the oxidative burst |
| PECAM1 (CD31) | Adhesion molecule involved in leukocyte transmigration | Relevant to neutrophil trafficking before clearance |
| SELPLG | Selectin ligand mediating neutrophil rolling and recruitment | Context for where neutrophils accumulate before clearance |
| FCGR3B (CD16) | Fc receptor on neutrophils and NK cells | Surface marker used to identify aged neutrophil populations |
| C5AR1 | Complement receptor driving neutrophil activation and chemotaxis | Modulates the inflammatory context of clearance |
How Is neutrophil clearance Regulated?
Neutrophil clearance is regulated at several levels. At the level of the target cell, aging programs change chemokine receptor expression, notably CXCR4, which directs senescent neutrophils back to CXCL12-rich marrow niches for elimination. At the level of the phagocyte, recognition is controlled by checkpoint molecules such as CD24, whose dysregulation impairs clearance in JAK2V617F myeloproliferative neoplasms. At the level of the whole organism, clearance is under circadian control, so that rhythmic removal of aged neutrophils modulates the hematopoietic niche. Inflammatory context also regulates clearance efficiency: pathogens such as Staphylococcus aureus can reprogram neutrophil metabolism through itaconate production, suppressing the oxidative burst and altering the inflammatory milieu in which clearance occurs. Finally, tissue-specific macrophage populations set the local capacity for clearance, and restoring this capacity can limit organ aging.
neutrophil clearance and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JAK2 | JAK2V617F myeloproliferative neoplasms with defective neutrophil clearance and myelofibrosis | JAK2V617F knock-in hematopoietic cells with macrophage clearance assays |
| CD24 | Immune checkpoint mediating recognition of aged neutrophils; dysregulated in myeloproliferative neoplasms | CD24 knockout and tagged knock-in in macrophage-neutrophil co-culture |
| CXCR4 | Circadian return of aged neutrophils to bone marrow niches for clearance | CXCR4 point-mutation or conditional knockout with circadian sampling |
| MERTK | Macrophage efferocytosis of senescent neutrophils | MERTK knockout macrophages with phagocytosis assays |
| ACOD1 (IRG1) | Pathogen-driven itaconate production suppressing the neutrophil oxidative burst | ACOD1 knockout neutrophils challenged with Staphylococcus aureus |
Myeloproliferative neoplasms and myelofibrosis
Defective neutrophil clearance is a driver of disease in JAK2V617F myeloproliferative neoplasms, where impaired elimination of senescent neutrophils promotes myelofibrosis through the immune checkpoint CD24. This establishes clearance failure as a causal mechanism rather than an incidental finding, and it identifies CD24 and the clearance machinery as candidate therapeutic targets. The link also explains why neutrophil accumulation in the marrow niche can remodel the hematopoietic environment.
Neutrophilic airway disease
In bronchiectasis, neutrophilic inflammation reflects an imbalance between neutrophil recruitment into the airway and effective clearance. Persistent neutrophils and their products contribute to airway damage, making clearance efficiency a relevant pathophysiological variable. This context also illustrates how pathogens and inflammatory signals can modulate neutrophil effector programs, as shown for Staphylococcus aureus and itaconate-mediated suppression of the oxidative burst.
Cerebral ischemia-reperfusion injury
Neutrophil mobilization after cerebral ischemia-reperfusion injury triggers microglial functional change and exacerbates injury. This demonstrates that the fate of neutrophils after injury, including their clearance, influences non-phagocytic cell populations such as microglia and thereby shapes neurological outcome. Targeting neutrophil dynamics is therefore of interest in neuroinflammation research.
Organ aging
Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging, linking GO:0097350 to age-related tissue deterioration. This finding positions clearance as a protective process whose decline may contribute to aging phenotypes. It also connects clearance biology to the broader immunology of aging and to macrophage function in aged tissues.
From neutrophil clearance-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate receptor required for senescent neutrophil uptake? | Macrophage knockout of the receptor with neutrophil co-culture and efferocytosis readouts |
| Does a disease variant impair clearance? | Point-mutation knock-in of the variant in hematopoietic cells followed by clearance assays |
| Where and when does clearance occur in vivo? | Tagged knock-in reporter of the receptor or ligand with circadian imaging |
| Does increased clearance limit organ aging? | Overexpression of the clearance receptor in tissue-resident macrophages |
| Which genes control neutrophil aging before clearance? | CRISPR library screening in neutrophil-like cell lines with surface marker sorting |
| How does injury change neutrophil fate? | Cerebral ischemia-reperfusion model with neutrophil tracking and microglial readouts |
How to Study the neutrophil clearance Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Macrophage-neutrophil co-culture | Uptake of senescent neutrophils | Testing receptor requirement for clearance |
| Flow cytometry | Frequency and phenotype of aged neutrophils | Tracking CXCR4-high populations over time |
| Circadian sampling of bone marrow | Rhythmic clearance and niche modulation | Linking clearance to granulopoiesis |
| Genetic knockout in macrophages | Causal role of a candidate receptor | Assigning function to MERTK, AXL or CD24 |
| Disease model with JAK2V617F | Clearance defect and myelofibrosis | Testing CD24-dependent mechanisms |
| Ischemia-reperfusion model | Neutrophil mobilization and microglial change | Studying injury-driven neutrophil fate |
| Pathogen challenge assay | Itaconate production and oxidative burst | Contextualizing neutrophil effector modulation |
| CRISPR library screening | Genes controlling neutrophil aging and recognition | Discovery of new clearance regulators |
Phagocytosis and efferocytosis assays
The core measurement in neutrophil clearance research is the uptake of senescent neutrophils by macrophages. Co-culture assays with labeled aged neutrophils and macrophages allow quantification of recognition and internalization, and they can be combined with receptor blockade or knockout to assign function. These assays are the primary way to test whether a candidate gene such as MERTK, AXL or CD24 is required for clearance.
Flow cytometry and surface phenotyping
Because clearance is selective for aged neutrophils, surface phenotyping is essential. Markers such as CXCR4 and Fc receptors distinguish aged from fresh neutrophils, and flow cytometry can track their frequency in blood, marrow and tissues over time. This approach is also used to monitor the effects of circadian phase on the size of the aged neutrophil pool.
In vivo clearance and circadian sampling
In vivo models allow clearance to be studied in its physiological context. Rhythmic modulation of the hematopoietic niche through neutrophil clearance was demonstrated by sampling marrow across the circadian cycle, showing that clearance oscillates and shapes granulopoiesis. Similar designs can be used to test whether a genetic perturbation changes the timing or magnitude of clearance.
Disease and injury models
Clearance defects are best studied in disease-relevant models. JAK2V617F myeloproliferative neoplasm models reveal impaired clearance and downstream myelofibrosis through CD24, while cerebral ischemia-reperfusion models reveal how neutrophil mobilization changes microglial function. Bronchiectasis and neutrophilic airway models provide a complementary setting in which recruitment and clearance are imbalanced.
How CRISPR Can Be Used to Study GO:0097350 neutrophil clearance
Knockout
CRISPR knockout is used to remove candidate clearance genes in macrophages or neutrophil-like cells and then measure whether senescent neutrophil uptake is impaired. This is the most direct way to test causality for receptors such as MERTK, AXL or CD24 in efferocytosis assays. Knockout of chemokine axis components can also be used to test the aging and homing steps that precede clearance.
Point Mutation
Point-mutation models are valuable when a specific disease variant, such as JAK2V617F, is suspected of impairing clearance. Introducing the variant into hematopoietic cells allows clearance assays to be performed against a defined genetic background, linking the mutation to defective elimination of senescent neutrophils and downstream pathology. Point mutations can also be used to dissect signaling residues in receptors that mediate recognition.
Knock-in
Knock-in of reporters or tags allows clearance to be visualized and quantified in vivo. Tagged knock-in of receptors or ligands enables tracking of aged neutrophils and macrophages across tissues and circadian phases. Knock-in of disease-associated alleles provides a physiologically faithful model for studying how a variant changes clearance efficiency.
Overexpression
Overexpression of clearance receptors in tissue-resident macrophages can test whether increasing clearance capacity is beneficial. This approach was used conceptually to show that restored clearance of senescent neutrophils limits organ aging. Overexpression can also be used to amplify a rate-limiting recognition step in order to study downstream degradation and feedback on granulopoiesis.
How EDITGENE Supports neutrophil clearance Research
Researchers studying neutrophil clearance-related genes often need to determine whether a candidate gene is causally involved in the recognition, uptake or autoregulatory feedback steps of GO:0097350, and this requires precise, reproducible genetic models rather than correlative observation alone.
Contact EDITGENE today to design your custom CRISPR model for neutrophil clearance research.
Frequently Asked Questions About neutrophil clearance
What is GO:0097350 neutrophil clearance?
GO:0097350 neutrophil clearance is the biological process defined as the selective elimination of senescent neutrophils from the body by autoregulatory mechanisms.
What genes are involved in neutrophil clearance?
Key genes include CXCR4 and CXCL12 in the aging and homing step, CD24 as a recognition checkpoint, JAK2 in disease-associated clearance failure, and macrophage receptors such as MERTK and AXL in uptake.
Which cells perform neutrophil clearance?
Tissue-resident macrophages are the principal effectors, engulfing senescent neutrophils in organs such as the bone marrow, and their capacity determines local clearance efficiency.
Why is neutrophil clearance important?
It prevents accumulation of aged neutrophils and release of their toxic contents, modulates granulopoiesis, and when defective contributes to myelofibrosis, airway inflammation and organ aging.
Is neutrophil clearance circadian?
Yes. Neutrophil aging and clearance oscillate over the circadian cycle, and rhythmic clearance in the bone marrow modulates the hematopoietic niche.
How is neutrophil clearance linked to myelofibrosis?
In JAK2V617F myeloproliferative neoplasms, defective clearance of senescent neutrophils drives myelofibrosis through the immune checkpoint CD24.
Can restoring neutrophil clearance affect aging?
Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging, indicating that clearance capacity is protective in aged tissues.
What methods are used to study neutrophil clearance?
Common methods include macrophage-neutrophil co-culture, flow cytometry of aged neutrophil markers, circadian bone marrow sampling, disease models and CRISPR screens.
How do pathogens influence neutrophil clearance?
Pathogens can reprogram neutrophil effector programs; Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst, altering the inflammatory context of clearance.
What CRISPR models are used for neutrophil clearance research?
Knockout, point-mutation, knock-in reporter and overexpression models in macrophages and neutrophil-like cells are used to test recognition, uptake and feedback steps.
Conclusion
GO:0097350 neutrophil clearance is a selective, autoregulatory process by which senescent neutrophils are removed from the body, chiefly by tissue-resident macrophages. Its importance spans homeostatic control of granulopoiesis, circadian regulation of the hematopoietic niche, and protection against tissue damage from persistent neutrophils. Defective clearance is now mechanistically linked to myeloproliferative neoplasms and myelofibrosis through CD24, to neutrophilic airway disease, and to ischemia-reperfusion injury, while restored clearance limits organ aging. Because the process depends on defined recognition and uptake steps, it is well suited to CRISPR-based dissection using knockout, point-mutation, knock-in and overexpression models.
References
- 1. Singhal A et al.. 2022. Neutrophil and remnant clearance in immunity and inflammation.. Immunology 165(1):22-43 PMID: 34704249
- 2. Papayannopoulos V. 2018. Neutrophil extracellular traps in immunity and disease.. Nat Rev Immunol 18(2):134-147 PMID: 28990587
- 3. Khatib-Massalha E et al.. 2025. Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.. Blood 146(6):717-731 PMID: 40373279
- 4. Tan YJ et al.. 2026. Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.. Science 393(6808):eaea3075 PMID: 42462036
- 5. Casanova-Acebes M et al.. 2013. Rhythmic modulation of the hematopoietic niche through neutrophil clearance.. Cell 153(5):1025-35 PMID: 23706740
- 6. Chalmers JD et al.. 2025. Neutrophilic inflammation in bronchiectasis.. Eur Respir Rev 34(176) PMID: 40174958
- 7. Tomlinson KL et al.. 2023. Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst.. Cell Rep 42(2):112064 PMID: 36724077
- 8. Jin H et al.. 2025. Neutrophil Mobilization Triggers Microglial Functional Change to Exacerbate Cerebral Ischemia-Reperfusion Injury.. Adv Sci (Weinh) 12(36):e03722 PMID: 40557450
